![Mark W. Durand](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark W. Durand
Keine laufenden Positionen mehr
Karriereverlauf von Mark W. Durand
Ehemalige bekannte Positionen von Mark W. Durand
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SORRENTO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 11.03.2014 | 30.04.2015 |
Finanzdirektor/CFO | 30.04.2015 | 23.06.2015 | |
Independent Dir/Board Member | 11.03.2014 | 30.04.2015 | |
Actavis, Inc.
![]() Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Finanzdirektor/CFO | 26.11.2007 | 27.07.2009 |
ERBA DIAGNOSTICS, INC. | Direktor/Vorstandsmitglied | 19.04.2006 | 02.09.2008 |
BRISTOL-MYERS SQUIBB COMPANY | Finanzdirektor/CFO | 01.01.1987 | 01.01.2004 |
Corporate Officer/Principal | 01.01.1987 | - | |
Teva North America | Finanzdirektor/CFO | - | - |
Ausbildung von Mark W. Durand
Duke University | Undergraduate Degree |
Dartmouth College | Graduate Degree |
The University of Chicago | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 9 |
Operativ
Director of Finance/CFO | 4 |
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
SORRENTO THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
ERBA Diagnostics, Inc.
![]() ERBA Diagnostics, Inc. Medical SpecialtiesHealth Technology ERBA Diagnostics, Inc. was engaged in manufacturing and marketing of proprietary diagnostic reagents, test kits and instrumentation in the areas of autoimmune, chemistry, hematology, diabetes, and infectious diseases. The company was founded on March 14, 2001 and was headquartered in Miami Lakes, FL. | Health Technology |
Teva North America | |
Actavis, Inc.
![]() Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Health Technology |
- Börse
- Insiders
- Mark W. Durand
- Erfahrung